logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Indications
    3. Malignant Neoplasm Of Ovary

    Medications for Malignant Neoplasm Of Ovary

    FiltersReset Filters
    4 results

    • cytalux

      (Pafolacianine injection)
      On Target Laboratories, Inc.
      Usage: CYTALUX is indicated as an adjunct for intraoperative identification of malignant lesions in adult patients with ovarian cancer and for both malignant and non-malignant pulmonary lesions in adult patients with known or suspected lung cancer.

    • gemcitabine

      (GEMCITABINE)
      Hospira, Inc.
      Usage: Gemcitabine Injection is indicated for treatment of advanced ovarian cancer (with carboplatin), metastatic breast cancer (with paclitaxel), non-small cell lung cancer (with cisplatin), and as first-line therapy for locally advanced or metastatic pancreatic cancer.

    • gemcitabine

      (GEMCITABINE)
      Fresenius Kabi USA, LLC
      Usage: Gemcitabine for Injection is indicated for advanced ovarian cancer (after platinum therapy), metastatic breast cancer (after anthracycline failure), non-small cell lung cancer (inoperable or metastatic), and pancreatic cancer (locally advanced or metastatic, following fluorouracil treatment).

    • topotecan hydrochloride

      (TOPOTECAN HYDROCHLORIDE)
      Fresenius Kabi USA, LLC
      Usage: Topotecan hydrochloride is indicated for treating metastatic ovarian cancer after chemotherapy progression, small cell lung cancer in platinum-sensitive patients post-first-line treatment progression, and Stage IV-B cervical cancer in combination with cisplatin, for patients not eligible for curative treatment.